

Preeclampsia (PE) – a hypertensive disorder affecting 3–8% of pregnancies—is now linked to long-term cerebrovascular damage and worsened stroke outcomes, according to a new study led by Prof. Marilyn J. Cipolla from the University of Vermont and published in Neuroprotection (April 13, 2025). Women with a history of PE are already known to be at higher risk for hypertension and cognitive decline later in life. This new research adds another layer of concern: lasting damage to the brain’s vascular system and an increased sensitivity to ischemic stroke.
New Research Shows Long-Term Brain Changes
Using an experimental model, the researchers induced preeclampsia in pregnant rats and evaluated their cerebral health 4–9 months postpartum. They discovered that those with prior PE showed significantly worse stroke outcomes—including larger infarcts, more cerebral swelling, and reduced blood perfusion -compared to control rats.
A key finding was the persistent elevation of oxidative stress markers, which may explain increased brain vulnerability. Additionally, small arteries responsible for alternate blood flow during stroke (pial collaterals) showed abnormal constriction, reducing their ability to compensate during ischemia.
Understanding the Preeclampsia-Stroke Connection
This study highlights the long-lasting impact of preeclampsia on cerebrovascular health, well beyond pregnancy. Prof. Cipolla notes that targeting the underlying mechanisms—like oxidative stress and vascular dysfunction—could help prevent future strokes and improve cardiovascular care for women who experienced PE.
To stay updated on the latest advancements in cerebrovascular health and stroke care, explore our Neurology CME/CE Conferences and Online Courses.
With continued research, these findings could guide new clinical strategies, early interventions, and awareness programs for stroke prevention in postpartum women with a history of PE.
For more information: Kropf, A., et al. (2025). History of pre‐eclampsia negatively impacts stroke severity postpartum in rats. Neuroprotection. doi.org/10.1002/nep3.70002.
more recommended stories
Statins and Depression: No Added Benefit
What Are Statins Used For? Statins.
Azithromycin Resistance Rises After Mass Treatment
Mass drug administration (MDA) of azithromycin.
Generative AI in Health Campaigns: A Game-Changer
Mass media campaigns have long been.
Molecular Stress in Aging Neurons Explained
As the population ages, scientists are.
Higher BMI and Hypothyroidism Risk Study
A major longitudinal study from Canada.
Therapeutic Plasma Exchange Reduces Biological Age
Therapeutic plasma exchange (TPE), especially when.
Childhood Cancer Diagnosis Delays Persist
Delays in childhood cancer diagnosis remain.
Hypothalamic Changes in Eating Disorders Explained
Groundbreaking MRI scans reveal microstructural hypothalamic.
Rapid Blood Test for Rare Diseases Revolutionizes Pediatric Diagnosis
A groundbreaking blood test developed by.
Blood Markers for Teen Depression: A Breakthrough in Early Detection
Mental health professionals and researchers have.
Leave a Comment